| Basics |
|
PharmaCyte Biotech, Inc.
|
| IPO Date: |
December 5, 2003 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$6.65M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.06 | 2.64%
|
| Avg Daily Range (30 D): |
$0.03 | 2.80%
|
| Avg Daily Range (90 D): |
$0.03 | 3.38%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.44M |
| Avg Daily Volume (30 D): |
.07M |
| Avg Daily Volume (90 D): |
.06M |
| Trade Size |
| Avg Trade Size (Sh.): |
236 |
| Avg Trade Size (Sh.) (30 D): |
340 |
| Avg Trade Size (Sh.) (90 D): |
304 |
| Institutional Trades |
| Total Inst.Trades: |
16 |
| Avg Inst. Trade: |
$1.4M |
| Avg Inst. Trade (30 D): |
$1.07M |
| Avg Inst. Trade (90 D): |
$1.07M |
| Avg Inst. Trade Volume: |
.37M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$.52M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
209.41K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-1.23
|
$1.52
|
$3.19
|
|
Diluted EPS
|
$-1.23
|
$1.52
|
$3.19
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -8.36M
|
$ 11.75M
|
$ 30.66M
|
|
Operating Income / Loss
|
$ -.85M
|
$ -1.04M
|
$ -4.38M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -1.99M
|
$ -1.21M
|
$ -35.01M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jul 12, 2021:
1:1500
|
|
Dec 08, 2003:
3:1
|
|
|
|